|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: IMMUNOMEDICS INC, 10-Q, EX-99, 2000-11-14 |
Next: ERESOURCE CAPITAL GROUP INC, 10QSB, 2000-11-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<CIK> 0000722830
<NAME> IMMUNOMEDICS, INC.
<MULTIPLIER> 1
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> JUN-30-2001
<PERIOD-START> JUL-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 8,408,862
<SECURITIES> 31,620,545
<RECEIVABLES> 1,203,451
<ALLOWANCES> (64,898)
<INVENTORY> 1,023,865
<CURRENT-ASSETS> 43,341,016
<PP&E> 11,865,880
<DEPRECIATION> (7,998,781)
<TOTAL-ASSETS> 47,433,115
<CURRENT-LIABILITIES> 3,465,525
<BONDS> 0
0
0
<COMMON> 494,799
<OTHER-SE> 43,262,292
<TOTAL-LIABILITY-AND-EQUITY> 47,433,115
<SALES> 1,238,144
<TOTAL-REVENUES> 2,036,451
<CGS> 57,092
<TOTAL-COSTS> 3,517,541
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> (1,481,090)
<INCOME-TAX> 0
<INCOME-CONTINUING> (1,481,090)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (1,481,090)
<EPS-BASIC> (0.03)
<EPS-DILUTED> (0.03)
</TABLE>
|
|